Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7

Molecular Oncology

Volumn 1, Issue 3, 2007, Pages 350-355

  Lindquist, David ^a   Romanitan, Mircea ^a   Hammarstedt, Lalle ^a   Näsman, Anders ^a   Dahlstrand, Hanna ^a   Lindholm, Johan ^a   Onelöv, Liselotte ^a   Ramqvist, Torbjörn ^a   Ye, Weimin ^a   Munck Wikland, Eva ^a   Dalianis, Tina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

E6 mRNA; E7 mRNA; Head and neck squamous cell carcinoma; Human papillomavirus; Tonsillar carcinoma; Viral load

Indexed keywords

MESSENGER RNA; PROTEIN E6; PROTEIN E7;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; ONCOGENE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; TONSIL CANCER; TUMOR BIOPSY; VERRUCA VULGARIS; VIRUS LOAD;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 36549011250     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2007.08.005     Document Type: Article

References (27)

1. Alani R.M., and Munger K. Human papillomaviruses and associated malignancies. J. Clin. Oncol. 16 (1998) 330-337
2. Andl T., Kahn T., Pfuhl A., Nicola T., Erber R., Conradt C., Klein W., Helbig M., Dietz A., Weidauer H., et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res. 58 (1998) 5-13
3. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 2 (2000) 169-193
4. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., Westra W.H., and Gillison M.L. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356 (2007) 1944-1956
5. Dahlgren L., Dahlstrand H., Lindquist D., Hogmo A., Bjornestal L., Lindholm J., Lundberg B., Dalianis T., and Munck-Wikland E. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int. J. Cancer 112 (2004) 1015-1019
6. Dahlgren L., Erlandsson F., Lindquist D., Silfversward C., Hellstrom A.C., and Dalianis T. Differences in human papillomavirus type may influence clinical outcome in early stage cervical cancer. Anticancer Res. 26 (2006) 829-832
7. de Boer M.A., Jordanova E.S., Kenter G.G., Peters A.A., Corver W.E., Trimbos J.B., and Fleuren G.J. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. Clin. Cancer Res. 13 (2007) 132-138
8. Frisch M., and Goodman M.T. Human papillomavirus-associated carcinomas in Hawaii and the mainland. U.S. Cancer 88 (2000) 1464-1469
9. Gillison M.L. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin. Oncol. 31 (2004) 744-754
10. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., Zahurak M.L., Daniel R.W., Viglione M., Symer D.E., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92 (2000) 709-720
11. Gillison M.L., and Shah K.V. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr. Opin. Oncol. 13 (2001) 183-188
12. Hammarstedt L., Lindquist D., Dahlstrand H., Romanitan M., Onelöv (Dahlgren) L., Joneberg J., Creson N., Lindholm J., Ye W., Dalianis T., and Munck-Wikland E. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int. J. Cancer 119 (2006) 2620-2623
13. Hammarstedt L., Dahlstrand H., Lindquist D., Onelov L., Ryott M., Luo J., Dalianis T., Ye W., and Munck-Wikland E. The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 127 (2007) 988-992
14. Kim S.H., Koo B.S., Kang S., Park K., Kim H., Lee K.R., Lee M.J., Kim J.M., Choi E.C., and Cho N.H. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int. J. Cancer 120 (2007) 1418-1425
15. Klussmann J.P., Weissenborn S.J., Wieland U., Dries V., Kolligs J., Jungehuelsing M., Eckel H.E., Dienes H.P., Pfister H.J., and Fuchs P.G. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92 (2001) 2875-2884
16. Li W., Thompson C.H., O'Brien C.J., McNeil E.B., Scolyer R.A., Cossart Y.E., Veness M.J., Walker D.M., Morgan G.J., and Rose B.R. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int. J. Cancer 106 (2003) 553-558
17. Mellin H., Friesland S., Lewensohn R., Dalianis T., and Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int. J. Cancer 89 (2000) 300-304
18. Mellin H., Dahlgren L., Munck-Wikland E., Lindholm J., Rabbani H., Kalantari M., and Dalianis T. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int. J. Cancer 102 (2002) 152-158
19. Mork J., Lie A.K., Glattre E., Hallmans G., Jellum E., Koskela P., Moller B., Pukkala E., Schiller J.T., Youngman L., Lehtinen M., and Dillner J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 344 (2001) 1125-1131
20. Ritchie J.M., Smith E.M., Summersgill K.F., Hoffman H.T., Wang D., Klussmann J.P., Turek L.P., and Haugen T.H. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int. J. Cancer 104 (2003) 336-344
21. Si H.X., Tsao S.W., Poon C.S., Wang L.D., Wong Y.C., and Cheung A.L. Viral load of HPV in esophageal squamous cell carcinoma. Int. J. Cancer 103 (2003) 496-500
22. Snijders P.J., Cromme F.V., van den Brule A.J., Schrijnemakers H.F., Snow G.B., Meijer C.J., and Walboomers J.M. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int. J. Cancer 51 (1992) 845-850
23. Syrjanen S. HPV infections and tonsillar carcinoma. J. Clin. Pathol. 57 (2004) 449-455
24. van Houten V.M., Snijders P.J., van den Brekel M.W., Kummer J.A., Meijer C.J., van Leeuwen B., Denkers F., Smeele L.E., Snow G.B., and Brakenhoff R.H. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int. J. Cancer 93 (2001) 232-235
25. Weinberger P.M., Yu Z., Haffty B.G., Kowalski D., Harigopal M., Brandsma J., Sasaki C., Joe J., Camp R.L., Rimm D.L., and Psyrri A. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J. Clin. Oncol. 24 (2006) 736-747
26. Venuti A., Badaracco G., Rizzo C., Mafera B., Rahimi S., and Vigili M. Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. J. Exp. Clin. Cancer Res. 23 (2004) 561-566
27. Wiest T., Schwarz E., Enders C., Flechtenmacher C., and Bosch F.X. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21 (2002) 1510-1507